Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001564590-21-029756
Filing Date
2021-05-25
Accepted
2021-05-25 16:06:12
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 achv-424b5.htm 424B5 647360
2 GRAPHIC glxfhwjhpatc000003.jpg GRAPHIC 3906
3 GRAPHIC glxfhwjhpatc000002.jpg GRAPHIC 4196
4 GRAPHIC glxfhwjhpatc000001.jpg GRAPHIC 3906
  Complete submission text file 0001564590-21-029756.txt   665574
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-229019 | Film No.: 21960619
SIC: 2835 In Vitro & In Vivo Diagnostic Substances